Douglas E. Fleming III


Douglas E. Fleming III


New York | Three Bryant Park, 1095 Avenue of the Americas, New York, NY, United States of America 10036-6797
+1 212 649 8703 | +1 212 698 3599

| vCard | PDF

Douglas E. Fleming III focuses on complex litigation, specifically matters concerning mass torts, product liability, environmental toxic torts, and insurance. Mr. Fleming regularly represents clients from the chemical, pharmaceutical, medical device, consumer product, building materials and insurance industries. His clients have included numerous Fortune 500 companies located nationwide involved in mass tort litigation filed across multiple federal and state jurisdictions. 

Mr. Fleming has extensive experience litigating cases at both the trial and appellate levels throughout the United States, including examining and preparing fact and expert witnesses for deposition, trial and legislative testimony. In addition to arguing complex motions before courts across multiple jurisdictions, Mr. Fleming has also written briefs in the United States Supreme Court. 

As a former New York City Public Attorney, Mr. Fleming has participated in numerous pro bono matters, acting as a key lawyer in multiple trials relating to high-profile shootings. He has represented the City of New York, as well as indigent plaintiffs and non-profit organizations.

In 2019, Chambers USA named Mr. Fleming a recognized practitioner for Product Liability & Mass Torts. Also in 2019, Legal 500 US recognized Mr. Fleming for his work in the areas of Product Liability, Mass Tort and Class Actions: pharmaceuticals and medical devices.

Prior to joining Dechert, Mr. Fleming was a partner at Quinn Emanuel Urquhart & Sullivan. 

  • Chemical manufacturers and processors in environmental mass tort litigations filed nationwide, including class actions and individual actions.
  • Firefighting foam manufacturers in individual and class action product liability lawsuits.
  • Major pharmaceutical manufacturers in multi-district product liability litigations alleging that prescription and generic medications caused personal injuries.
  • A building materials manufacturer in multi-district litigation, seeking monetary relief for allegedly defective products.
  • A major consumer product manufacturer in individual and aggregated product liability lawsuits alleging personal injuries and economic damages, as well as in related regulatory and legislative matters.
  • A robotic surgery manufacturer in medical device litigation.
  • A leading property and automobile insurer in a variety of actions, including class actions, coverage actions, and commercial actions.

Includes matters handled at Dechert or prior to joining the firm.

  • University of Notre Dame, B.A., 1991
  • St. John’s University School of Law, J.D., 1994, magna cum laude, Articles and Comments Editor of St. John’s Law Review
  • New York
  • New Jersey
  • Supreme Court of the United States
  • United States Court of Appeals for the Second Circuit
  • United States District Court for the District of Colorado
  • United States District Court for the Eastern District of New York
  • United States District Court for the Northern District of New York
  • United States District Court for the Southern District of New York
  • Vice-Chair, Pharmaceutical, Medical Device and Bioscience General Committee, Tort Trial & Insurance Practice Section of American Bar Association (September 2018-2019 term)
  • Board of Directors, St. John's University School of Law Alumni, New York Chapter